Home/ProMIS Neurosciences/Dr. Neil Cashman
DN

Dr. Neil Cashman

Chief Scientific Officer and Co-Founder

ProMIS Neurosciences

ProMIS Neurosciences Pipeline

DrugIndicationPhase
PMN310Alzheimer's DiseasePhase 1b
PMN442Amyotrophic Lateral Sclerosis (ALS)Preclinical
PMN331Parkinson's Disease / Multiple System AtrophyPreclinical